What’s New with TAVR? An Update on Device Technology
References
- Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004 Feb 18;43(4):698-703. doi: 10.1016/j.jacc.2003.11.026
- Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002 Dec 10;106(24):3006-8. doi: 10.1161/01.cir.0000047200.36165.b8
- Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932
- Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2020 Nov 24;76(21):2492-2516. doi: 10.1016/j.jacc.2020.09.595
- Cahill TJ, Chen M, Hayashida K, et al. Transcatheter aortic valve implantation: current status and future perspectives. Eur Heart J. 2018 Jul 21;39(28):2625-2634. doi: 10.1093/eurheartj/ehy244
- Tchetche D, Van Mieghem NM. New-generation TAVI devices: description and specifications. EuroIntervention. 2014 Sep;10 Suppl U:U90-U100. doi: 10.4244/EIJV10SUA13
- van Gils L, Tchetche D, Latib A, et al. TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery. EuroIntervention. 2016 Sep 18;12(Y):Y22-7. doi: 10.4244/EIJV12SYA6
- Chamandi C, Puri R, Rodriguez-Gabella T, Rodés-Cabau J. Latest-Generation Transcatheter Aortic Valve Replacement Devices and Procedures. Can J Cardiol. 2017 Sep;33(9):1082-1090. doi: 10.1016/j.cjca.2017.03.012
- Cannata S, Gandolfo C, Ribichini FL, et al. One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry. EuroIntervention. 2023 Mar 7;
EIJ-D-22-01022 . doi: 10.4244/EIJ-D-22-01022 - Nazif TM, Cahill TJ, Daniels D, et al. Real-World Experience With the SAPIEN 3 Ultra Transcatheter Heart Valve: A Propensity-Matched Analysis From the United States. Circ Cardiovasc Interv. 2021 Sep;14(9):
e010543 . doi: 10.1161/CIRCINTERVENTIONS.121.010543 - ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine;
c2023 . ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve; 2022 Dec 12 [cited 2023 Apr 20]. Available from:https://clinicaltrials.gov/ct2/show/NCT05172960 - Tang GHL, Zaid S, Michev I, et al. “Cusp-Overlap” View Simplifies Fluoroscopy-Guided Implantation of Self-Expanding Valve in Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2018 Aug 27;11(16):1663-1665. doi: 10.1016/j.jcin.2018.03.018
- Zaid S, Sengupta A, Okoli K, et al. Novel Anatomic Predictors of New Persistent Left Bundle Branch Block After Evolut Transcatheter Aortic Valve Implantation. Am J Cardiol. 2020 Apr 15;125(8):1222-1229. doi: 10.1016/j.amjcard.2020.01.008
- Yoon SH, Galo J, Amoah JK, et al. Permanent Pacemaker Insertion Reduction and Optimized Temporary Pacemaker Management After Contemporary Transcatheter Aortic Valve Implantation With Self-Expanding Valves (from the Pristine TAVI Study). Am J Cardiol. 2023 Feb 15;189:1-10. doi: 10.1016/j.amjcard.2022.11.026
- Doldi PM, Stolz L, Escher F, et al. Transcatheter Aortic Valve Replacement with the Self-Expandable Core Valve Evolut Prosthesis Using the Cusp-Overlap vs. Tricusp-View. J Clin Med. 2022 Mar 12;11(6):
1561 . doi: 10.3390/jcm11061561 - Gada H, Vora AN, Tang GHL, et al. Site-Level Variation and Predictors of Permanent Pacemaker Implantation Following TAVR in the Evolut Low-Risk Trial. Cardiovasc Revasc Med. 2023 Feb;47:48-54. doi: 10.1016/j.carrev.2022.10.004
- Khera S, Krishnamoorthy P, Sharma SK, et al. Improved Commissural Alignment in TAVR With the Newest Evolut FX Self-Expanding Supra-Annular Valve: First-in-Human Experience. JACC Cardiovasc Interv. 2023 Feb 27;16(4):498-500. doi: 10.1016/j.jcin.2022.10.041
- Tang GHL, Krishnamoorthy P, Khera S, et al.
First-in-Human Multicentre Experience of TAVI with the Supra-annular, Self-Expanding Evolut FX System . PCR London Valves Annual Meeting; London, UK; 2022. Paris: France; PCR Online; 2022. - Sondergaard L, Walton AS, Worthley SG, et al. Thirty-day and one-year outcomes of the Navitor transcatheter heart valve in patients with aortic stenosis: the prospective, multicentre, global PORTICO NG Study. EuroIntervention. 2023 Mar 9;
EIJ-D-22-01108 . doi: 10.4244/EIJ-D-22-01108 - ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine;
c2023 . Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation (VANTAGE); 2023 Jan 9 [cited 2023 Apr 20]. Available from:https://clinicaltrials.gov/ct2/show/NCT04788888 - Lanz J, Kim WK, Walther T, et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet. 2019 Nov 2;394(10209):1619-1628. doi: 10.1016/S0140-6736(19)32220-2
- Tamburino C, Bleiziffer S, Thiele H, et al. Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical Trial. Circulation. 2020 Dec 22;142(25):2431-2442. doi: 10.1161/CIRCULATIONAHA.120.051547
- Buono A, Gorla R, Ielasi A, et al. Transcatheter Aortic Valve Replacement With Self-Expanding ACURATE neo2: Postprocedural Hemodynamic and Short-Term Clinical Outcomes. JACC Cardiovasc Interv. 2022 Jun 13;15(11):1101-1110. doi: 10.1016/j.jcin.2022.02.027
- Ruck A. Results from the Early neo2 Registry Acurate neo2 TAVI Valve. Congress for the European Association of Percutaneous Cardiovascular Interventions (EuroPCR); 2021 May 18-20; Paris, France. Available from:
https://media.pcronline.com/diapos/EuroPCR2021/3890-20210518_0922_Clinical_Science_Ruck_Andreas_0000_(7805)/Ruck_Andreas_20211805_1408_VOD.pdf - ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine;
c2023 . ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement; 2023 Mar 30 [cited 2023 Apr 20]. Available from:https://clinicaltrials.gov/ct2/show/NCT03735667 - Yoon SH, Schmidt T, Bleiziffer S, et al. Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation. J Am Coll Cardiol. 2017 Dec 5;70(22):2752-2763. doi: 10.1016/j.jacc.2017.10.006
- Kempfert J, Rastan AJ, Mohr FW, Walther T. A new self-expanding transcatheter aortic valve for transapical implantation - first in man implantation of the JenaValve™. Eur J Cardiothorac Surg. 2011 Sep;40(3):761-3. doi: 10.1016/j.ejcts.2010.12.063
- Nijenhuis VJ, Swaans MJ, Michiels V, de Kroon T, Heijmen RH, Ten Berg JM. “First experience with JenaValve™: a single-centre cohort”. Neth Heart J. 2015 Jan;23(1):35-41. doi: 10.1007/s12471-014-0619-8
- Schäfer U, Schirmer J, Niklas S, Harmel E, Deuschl F, Conradi L. First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation. EuroIntervention. 2017 Dec 20;13(11):1296-1299. doi: 10.4244/EIJ-D-17-00502
- ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine;
c2023 . THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study; 2022 Nov 18 [cited 2023 Apr 20]. Available from:https://clinicaltrials.gov/ct2/show/NCT02732704 - ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine;
c2023 . JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study; 2022 Nov 22 [cited 2023 Apr 20]. Available from:https://clinicaltrials.gov/ct2/show/NCT02732691 - Vahl T, Makkar R, Kodali S, et al. 30-DAY OUTCOMES OF TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT FOR AORTIC REGURGITATION WITH A NOVEL SELF-EXPANDING PROSTHESIS. J Am Coll Cardiol. 2021 May;77(18):919. doi: 10.1016/S0735-1097(21)02278-6
- Ochi A, Cheng K, Zhao B, Hardikar AA, Negishi K. Patient Risk Factors for Bioprosthetic Aortic Valve Degeneration: A Systematic Review and Meta-Analysis. Heart Lung Circ. 2020 May;29(5):668-678. doi: 10.1016/j.hlc.2019.09.013
- Arsalan M, Walther T. Durability of prostheses for transcatheter aortic valve implantation. Nat Rev Cardiol. 2016 Jun;13(6):360-7. doi: 10.1038/nrcardio.2016.43
- Hahn RT, Webb J, Pibarot P, et al. 5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical Bioprostheses. JACC Cardiovasc Interv. 2022 Apr 11;15(7):698-708. doi: 10.1016/j.jcin.2022.02.014
- Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014 Jul;312(2):162-70. doi: 10.1001/jama.2014.7246
- Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg. 2005 Mar;79(3):1072-80. doi: 10.1016/j.athoracsur.2004.06.033
- Bavaria JE, Griffith B, Heimansohn DA, et al. Five-year Outcomes of the COMMENCE Trial Investigating Aortic Valve Replacement with RESILIA Tissue. Ann Thorac Surg. 2022 Jan 20;
S0003-4975(22)00063-7 . doi: 10.1016/j.athoracsur.2021.12.058 - Lim KH, Candra J, Yeo JH, Duran CMG. Flat or curved pericardial aortic valve cusps: a finite element study. J Heart Valve Dis. 2004 Sep;13(5):792-7. PMID: 15473482
- Brizard CP, Brink J, Horton SB, Edwards GA, Galati JC, Neethling WML. New engineering treatment of bovine pericardium confers outstanding resistance to calcification in mitral and pulmonary implantations in a juvenile sheep model. J Thorac Cardiovasc Surg. 2014 Dec;148(6):3194-201. doi: 10.1016/j.jtcvs.2014.08.002
- Neethling W, Rea A, Forster G, Bhirangi K. Performance of the ADAPT-Treated CardioCel® Scaffold in Pediatric Patients With Congenital Cardiac Anomalies: Medium to Long-Term Outcomes. Front Pediatr. 2020 Apr 24;8:198. doi: 10.3389/fped.2020.00198
- Meduri C, Bapat V, Kodali S, et al. TCT-471 First-in-Human Study Results With the Novel Anteris DurAVRTM Three-Dimensional Single-Piece TAVR Device. J Am Coll Cardiol. 2022 Sep;80(12):B190. doi: 10.1016/j.jacc.2022.08.556
- ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine;
c2023 . Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study (DurAVR™ EFS); 2023 Mar 10 [cited 2023 Apr 20]. Available from:https://www.clinicaltrials.gov/ct2/show/NCT05712161 - Bezuidenhout D, Williams DF, Zilla P. Polymeric heart valves for surgical implantation, catheter-based technologies and heart assist devices. Biomaterials. 2015 Jan;36:6-25. doi: 10.1016/j.biomaterials.2014.09.013
- Kereiakes DJ, Answini GA, Yakubov SJ, et al. Preliminary Evaluation of a Novel Polymeric Valve Following Surgical Implantation for Symptomatic Aortic Valve Disease. JACC Cardiovasc Interv. 2021 Dec 27;14(24):2754-2756. doi: 10.1016/j.jcin.2021.08.071
- ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine;
c2023 . Early Feasibility Study for the Foldax Tria Aortic Heart Valve; 2022 Feb 25 [cited 2023 Apr 20]. Available from:https://clinicaltrials.gov/ct2/show/NCT03851068 - Isrctn.com [Internet]. London, UK: Springer Nature;
c2023 . The role of cerebral embolic protection in preventing strokes and improving other health outcomes in patients receiving a replacement heart valve; 2022 Nov 11 [cited 2023 Apr 20]. Available from:https://www.isrctn.com/ISRCTN16665769
DOI: https://doi.org/10.14797/mdcvj.1230 | Journal eISSN: 1947-6108
Language: English
Page range: 4 - 14
Submitted on: Mar 14, 2023
Accepted on: Mar 15, 2023
Published on: May 16, 2023
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2023 Syed Zaid, Marvin D. Atkins, Neal S. Kleiman, Michael J. Reardon, Gilbert H. L. Tang, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.